Startup Atlas · Healthcare
Glenmark Pharmaceuticals Ltd Sector Top 20
UndisclosedTotal funding (tracked)
0Funding rounds
—Last round
Glenmark Pharmaceuticals Ltd: Financial Breakdown
Figures below are FY2026, consolidated basis, compiled from filings and disclosures — every year cited to its source.
INR 169825.11 million revenue from operationsTotal revenue
INR 131923.00 million total expensesTotal expenses
INR 13619.52 million total group PATNet profit
| Fiscal year | Revenue | Total expenses | EBITDA | Net profit / loss | Source |
|---|---|---|---|---|---|
| FY2026 | INR 169825.11 million revenue from operations | INR 131923.00 million total expenses | — | INR 13619.52 million total group PAT | source |
Nothing here is blurred or gated — every figure Atlas has is shown in full, free.
Sources & corrections.
Every fact on this page is compiled from cited public sources — follow the "source" links beside each entry. Profile sources: www.bseindia.com glenmark.b-cdn.net · Last verified 24 Oct 2026. · Report a correction